Population pharmacokinetic analysis of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in patients and healthy volunteers.

MLA

Yang, Eunsol, et al. “Population Pharmacokinetic Analysis of Zastaprazan (JP‐1366), a Novel Potassium‐competitive Acid Blocker, in Patients and Healthy Volunteers.” CPT: Pharmacometrics & Systems Pharmacology, vol. 13, no. 12, Dec. 2024, pp. 2150–58. EBSCOhost, https://doi.org/10.1002/psp4.13228.

APA

Yang, E., Hwang, I., Ji, S. C., Kim, J., & Lee, S. (2024). Population pharmacokinetic analysis of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in patients and healthy volunteers. CPT: Pharmacometrics & Systems Pharmacology, 13(12), 2150–2158. https://doi.org/10.1002/psp4.13228

Chicago

Yang, Eunsol, Inyoung Hwang, Sang Chun Ji, John Kim, and SeungHwan Lee. 2024. “Population Pharmacokinetic Analysis of Zastaprazan (JP‐1366), a Novel Potassium‐competitive Acid Blocker, in Patients and Healthy Volunteers.” CPT: Pharmacometrics & Systems Pharmacology 13 (12): 2150–58. doi:10.1002/psp4.13228.